临床前初步安全性评价结果表明，HQ1127安全范围大，在超过有效剂量50倍情况下仍未出现毒副作用。
Preclinical primary safety evaluation result indicates that HQ1127 has a wide safety range, since no toxicity has been observed at the level 50 times of the effective does.
临床前初步安全性评价结果表明，HQ1127安全范围大，在超过有效剂量50倍情况下仍未出现毒副作用。
Preclinical primary safety evaluation result indicates that HQ1127 has a wide safety range, since no toxicity has been observed at the level 50 times of the effective does.
应用推荐